Clinical Trials Logo

Mild Traumatic Brain Injury clinical trials

View clinical trials related to Mild Traumatic Brain Injury.

Filter by:

NCT ID: NCT01220713 Completed - Clinical trials for Mild Traumatic Brain Injury

Hyperbaric Oxygen Therapy (HBO2T) for Post-Concussive Symptoms (PSC) After Mild Traumatic Brain Injury (mTBI)

HBOT
Start date: June 2010
Phase: Phase 2
Study type: Interventional

The goal of this research is to serve as a demonstration project to determine the tolerability of individuals with persistent post-concussive symptoms from combat-related mild TBI (traumatic brain injury), identify dose-finding for HBO2 (Hyperbaric Oxygen) therapy, and determine the efficacy of HBO2 therapy.

NCT ID: NCT01101724 Completed - Clinical trials for Mild Traumatic Brain Injury

Effect of Early Rest on Recovery From Pediatric Concussion

Start date: April 2010
Phase: N/A
Study type: Interventional

The purpose of this study is to find out if strict rest for 5 days helps children get better after concussion.

NCT ID: NCT01044615 Completed - Clinical trials for Mild Traumatic Brain Injury

Advanced Imaging Tools in the Study of Mild Traumatic Brain Injury

mTBI
Start date: December 2010
Phase: N/A
Study type: Observational

We will utilize a set of imaging modalities including computed tomography (CT), positron emission tomography (PET), and a suite of magnetic resonance imaging (MRI) tools, to investigate the changes in the human brain resulting from mild traumatic brain injury (mTBI).

NCT ID: NCT01013870 Active, not recruiting - Clinical trials for Post-traumatic Stress Disorder

Mission Connect Mild Traumatic Brain Injury (TBI) Integrated Clinical Protocol

Start date: February 2010
Phase: Phase 2
Study type: Interventional

The purpose of this study is to improve the ability to diagnose problems after mild traumatic brain injury (MTBI) and to test a drug that may improve the outcome from these injuries. Of the more than 1.5 million people who experience a traumatic brain injury (TBI) each year in the United States, as many as 75% sustain a mild TBI which can cause long-term or permanent impairments/disabilities in a significant proportion of patients. In addition, traumatic brain injury has become a signature injury of the wars in Iraq and Afghanistan. For people with these injuries, it is difficult to determine whether symptoms are due to the head injury or another condition, such as Post-traumatic Stress Disorder. In this project, there are 3 observational studies that involve testing of mental functions and behavior, imaging of the brain with special x-ray procedures, and blood samples to look at glandular function, which may be affected by head injury. A fourth study is a test of a drug, atorvastatin, which may provide protection for injured brain cells and improve outcome. By collecting and analyzing the information from these tests, it will be possible to make the process of diagnosing mild TBI or post traumatic stress disorder (PTSD) more precise, and also to see if atorvastatin is a helpful drug for patients with MTBI.

NCT ID: NCT00893347 Completed - Clinical trials for Mild Traumatic Brain Injury

An Intervention Program to Reduce to the Risk of Persistent Symptoms After Concussion

Start date: June 2009
Phase: Phase 2
Study type: Interventional

This study investigates how well a new therapy program prevents persistent symptoms (e.g., headaches, fatigue, irritability, etc.) after concussion. The program involves examining beliefs about concussion and learning healthy coping strategies, and is completed with the first three months post-injury.

NCT ID: NCT00822263 Completed - Clinical trials for Mild Traumatic Brain Injury

The Use of Anti-oxidants to Reduce Sequela of Mild Traumatic Brain Injury (mTBI) After Blast Exposure

Start date: November 2008
Phase: N/A
Study type: Interventional

The administration of N-acetyl-cysteine (an anti-oxidant) for seven days along with observation will result in improved hearing and balance function in individuals who demonstrate these disorders after blast exposure when compared to a placebo medicine and observation at the seven day time point.

NCT ID: NCT00715949 Completed - Clinical trials for Mild Traumatic Brain Injury

Neurocognitive Evaluation of Mild Traumatic Brain Injury in the Hospitalized Pediatric Population

Start date: December 2005
Phase: N/A
Study type: Observational

Brain injuries from trauma are common in children, often resulting in death and disability. Most brain injuries are minor, yet their treatment can be challenging. Because there are many different scales used to characterize the severity of brain injury, there is no consensus regarding how to manage patients with minor brain injuries. Specifically, there is no agreement on recommendations regarding the safety of return to activities following injury. In young athletes with minor brain injuries (i.e. concussions) there is strong data suggesting that return to baseline neurologic function is often delayed by days or weeks. Children allowed to return to activities too soon may be at a higher risk for a second concussion, may delay recovery or, in rare cases, die. Researchers have designed a computer-based testing system (ImPACT©) to objectively test for neurologic deficits following injury. This test has been used primarily in athletes following a concussion but is also applicable to children with brain injuries from non-sports related traumas. We propose to utilize this testing in pediatric patients admitted to the hospital with minor brain injury. The test would be administered at the time of the hospitalization as well as in the outpatient trauma clinic at the time of routine follow up. The test would allow us to determine if there are neurologic deficits, potentially subclinical, in these brain injured patients and how quickly they recover from their injuries. If successful, the testing will likely be useful in other clinical settings such as the primary care office (e.g. pediatrician), specialty care office (e.g. sports medicine), or emergency room to determine if an injured child requires additional intervention.

NCT ID: NCT00580918 Withdrawn - Clinical trials for Mild Traumatic Brain Injury

Functional MRI Study of Attention in Normal Controls and Traumatic Brain Injured Patients

Start date: October 2003
Phase:
Study type: Observational

The purpose of this study will be to assess the attentional ability of patients with mild to moderate traumatic brain injury (TBI) using the functional Magnetic Resonance Imaging (fMRI) technique. Methodology for specific aim 1: sagittal pilot scan, 3-D anatomical MRI, Whole brain echo-planar imaging (EPI), and functional MRI techniques with traumatic brain injured subjects doing a Continuous Performance Test (CPT) attention task and compare the pattern of activation with those of normal controls to see if there is a failure to activate frontal lobes in the traumatic brain injured subjects.